Related Experiment Video
Updated: May 16, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
CD44 promotes Kras-dependent lung adenocarcinoma.
1Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Oncogene
|December 5, 2012
Summary
The cell surface molecule CD44 is crucial for Kras-driven lung adenocarcinoma growth. Removing CD44 in mice reduced tumor formation and improved survival, highlighting CD44 as a potential therapeutic target for lung cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Non-small cell lung adenocarcinoma (NSCLC) driven by Kras mutations represents a significant portion of lung cancers with poor patient outcomes.
- Oncogenic Kras signaling pathways are key drivers of tumor initiation and progression in various cancers, including lung adenocarcinoma.
Purpose of the Study:
- To investigate the role of the cell surface molecule CD44 in Kras-driven non-small cell lung adenocarcinoma.
- To determine the downstream signaling mechanisms by which CD44 influences tumor cell proliferation in this context.
Main Methods:
- Utilized a genetically engineered mouse model expressing a cre-mediated KrasG12D mutant to study lung adenocarcinoma development.
- Performed CD44 gene deletion experiments in the mouse model to assess its impact on tumor formation and survival.
- Analyzed the involvement of CD44 in Kras-mediated signaling pathways, specifically the mitogen-activated protein kinase (MAPK) pathway.
Main Results:
- Deletion of CD44 significantly attenuated the formation of lung adenocarcinoma in the Kras-driven mouse model.
- Mice with CD44 deletion exhibited prolonged survival compared to control groups.
- CD44 was found to be essential for the activation of Kras-mediated MAPK signaling, thereby promoting tumor cell proliferation.
Conclusions:
- CD44 plays a previously unrecognized critical role in the development of Kras-induced lung adenocarcinoma.
- Targeting CD44 presents a promising therapeutic strategy for inhibiting the progression of Kras-dependent lung carcinomas.
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...